Hyperfunction of CD4 CD25 regulatory T cells in de novo acute myeloid leukemia | BMC Cancer | Full Text

Hyperfunction of CD4 CD25 regulatory T cells in de novo acute myeloid leukemia | BMC Cancer | Full Text

Hyperfunction of CD4 CD25 regulatory T cells in de novo acute myeloid leukemia

Acute myeloid leukemia (AML) is a common hematopoietic malignancy that has a high relapse rate, and the number of regulatory T cells (Tregs) in AML patients is significantly increased. The aim of this study wa...

Authors:Yuling Wan, Congxiao Zhang, Yingxi Xu, Min Wang, Qing Rao, Haiyan Xing, Zheng Tian, Kejing Tang, Yingchang Mi, Ying Wang and Jianxiang Wang

Citation:BMC Cancer 2020 20:472

Content type:Research article

Published on: 26 May 2020

• ViewFull Text
 
• ViewPDF